• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Emergent BioSolutions launches over-the-counter Narcan nasal spray

August 30, 2023 By Sean Whooley

Emergent Biosolutions Narcan
Narcan. [Image from Emergent BioSolutions]
Emergent BioSolutions (NSYE:EBS) announced today that it plans to put its over-the-counter Narcan nasal spray on U.S. shelves next month.

FDA approved the over-the-counter Narcan spray in May. Approval enabled direct-to-consumer sales in places like drug stores, convenience stores and more. The FDA nod came about six weeks after an agency committee voted unanimously in favor of OTC use. It marked the first approval for a naloxone product for use without a prescription.

The naloxone HCl nasal spray (4 mg) will become available on shelves nationwide and online beginning in September. Over-the-counter (OTC) Narcan access enables wide accessibility to a tool that combats opioid emergencies. It can reverse the effects of opioids, including fentanyl.

Emergent BioSolutions expects to make the treatment available at leading mass drug, grocery and online retailers. The company said the Manufacturer’s Suggested Retail Price comes in at $44.99 per carton, or roughly $22.50 per dose. Emergent BioSolutions said in a news release that it works with partners to help maintain access and affordability. However, individual retailers determine the price of the product.

The company said in an effort to broaden distribution and maintain affordability, it lowered the public interest price to $41 per carton. That goes into effect Aug. 31, 2023, Emergent BioSolutions said. The company recently changed its strategy, including enacting 400 job cuts, to tighten its focus on Narcan.

“A steadfast commitment to expanding access to naloxone has always been at the forefront of our work to help save lives and we’re proud to bring Narcan nasal spray to many, many more places,” said Paul Williams, SVP, products business at Emergent BioSolutions. “Expanding availability to online and in-store shelves, increasing awareness and education to reduce stigma, and calling on the public to be prepared, is additive to the current work Emergent does every single day to stem the tide of this public health threat.

“On the eve of International Overdose Awareness Day, we stand by our ongoing efforts with advocates, patients, customers and policy stakeholders to implement efforts that enhance naloxone distribution to all those in need.”

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: Emergent BioSolutions, Narcan

IN CASE YOU MISSED IT

  • Glucotrack to effect a reverse stock split
  • Medtronic unveils ‘MiniMed’ as name for soon-to-be separated Diabetes unit
  • Insulet, Marvel collab to unveil comic book hero with type 1 diabetes
  • Insulet rolls out new Omnipod 5 iPhone app for use with Dexcom G7
  • Tandem, Abbott strike deal to pair insulin pumps with glucose-ketone monitor

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS